Portunus trituberculatus isolate SZX2019 chromosome 16, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030086.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GFFJ01073592.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 361 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 361 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
monocarboxylate transporter 10-like, transcript variant X1
monocarboxylate transporter 10-like, transcript variant X3
monocarboxylate transporter 10-like, transcript variant X2
monocarboxylate transporter 10-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
monocarboxylate transporter 10-like isoform X1
monocarboxylate transporter 10-like isoform X2
monocarboxylate transporter 10-like isoform X3
ubiquitin domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ubiquitin domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
ubiquitin domain-containing protein 1-like isoform X2
ubiquitin domain-containing protein 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X2
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X3
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X6
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X5
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X1
mitogen-activated protein kinase kinase kinase 7-like isoform X6
probable serine/threonine-protein kinase DDB_G0278665 isoform X2
mitogen-activated protein kinase kinase kinase 7-like isoform X5
mitogen-activated protein kinase kinase kinase 7-like isoform X3
serine/threonine-protein kinase phg2-like isoform X1
mitogen-activated protein kinase kinase kinase 7-like, transcript variant X4
serine/threonine-protein kinase phg2-like isoform X4
G patch domain-containing protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: G patch domain-containing protein 3-like
uncharacterized LOC123504460, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC123504460, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
vacuolar protein sorting-associated protein 29, transcript variant X1
vacuolar protein sorting-associated protein 29 isoform X1
vacuolar protein sorting-associated protein 29, transcript variant X2
vacuolar protein sorting-associated protein 29 isoform X2
mediator of RNA polymerase II transcription subunit 12-like protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mediator of RNA polymerase II transcription subunit 12-like protein
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
40S ribosomal protein S18, transcript variant X1
40S ribosomal protein S18, transcript variant X4
40S ribosomal protein S18, transcript variant X2
40S ribosomal protein S18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 224 Proteins
zwei Ig domain protein zig-8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X1
lateral signaling target protein 2 homolog
LOW QUALITY PROTEIN: lateral signaling target protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
C-type lectin domain family 17, member A-like
uncharacterized LOC123504416, transcript variant X4
uncharacterized LOC123504416, transcript variant X2
uncharacterized LOC123504416, transcript variant X1
uncharacterized LOC123504416, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
microtubule-actin cross-linking factor 1-like, transcript variant X11
microtubule-actin cross-linking factor 1-like, transcript variant X7
microtubule-actin cross-linking factor 1-like, transcript variant X40
microtubule-actin cross-linking factor 1-like, transcript variant X36
microtubule-actin cross-linking factor 1-like, transcript variant X27
microtubule-actin cross-linking factor 1-like, transcript variant X8
microtubule-actin cross-linking factor 1-like, transcript variant X32
microtubule-actin cross-linking factor 1-like, transcript variant X15
microtubule-actin cross-linking factor 1-like, transcript variant X3
microtubule-actin cross-linking factor 1-like, transcript variant X45
microtubule-actin cross-linking factor 1-like, transcript variant X46
microtubule-actin cross-linking factor 1-like, transcript variant X20
microtubule-actin cross-linking factor 1-like, transcript variant X17
microtubule-actin cross-linking factor 1-like, transcript variant X2
microtubule-actin cross-linking factor 1-like, transcript variant X34
microtubule-actin cross-linking factor 1-like, transcript variant X42
microtubule-actin cross-linking factor 1-like, transcript variant X28
microtubule-actin cross-linking factor 1-like, transcript variant X16
microtubule-actin cross-linking factor 1-like, transcript variant X14
microtubule-actin cross-linking factor 1-like, transcript variant X44
microtubule-actin cross-linking factor 1-like, transcript variant X39
microtubule-actin cross-linking factor 1-like, transcript variant X37
microtubule-actin cross-linking factor 1-like, transcript variant X35
microtubule-actin cross-linking factor 1-like, transcript variant X30
microtubule-actin cross-linking factor 1-like, transcript variant X29
microtubule-actin cross-linking factor 1-like, transcript variant X21
microtubule-actin cross-linking factor 1-like, transcript variant X33
microtubule-actin cross-linking factor 1-like, transcript variant X31
microtubule-actin cross-linking factor 1-like, transcript variant X22
microtubule-actin cross-linking factor 1-like, transcript variant X13
microtubule-actin cross-linking factor 1-like, transcript variant X6
microtubule-actin cross-linking factor 1-like, transcript variant X18
microtubule-actin cross-linking factor 1-like, transcript variant X9
microtubule-actin cross-linking factor 1-like, transcript variant X23
microtubule-actin cross-linking factor 1-like, transcript variant X19
microtubule-actin cross-linking factor 1-like, transcript variant X12
microtubule-actin cross-linking factor 1-like, transcript variant X10
microtubule-actin cross-linking factor 1-like, transcript variant X4
microtubule-actin cross-linking factor 1-like, transcript variant X5
microtubule-actin cross-linking factor 1-like, transcript variant X1
microtubule-actin cross-linking factor 1-like, transcript variant X38
microtubule-actin cross-linking factor 1-like, transcript variant X41
microtubule-actin cross-linking factor 1-like, transcript variant X25
microtubule-actin cross-linking factor 1-like, transcript variant X26
microtubule-actin cross-linking factor 1-like, transcript variant X24
microtubule-actin cross-linking factor 1-like, transcript variant X43
microtubule-actin cross-linking factor 1-like, transcript variant X47
microtubule-actin cross-linking factor 1-like isoform X11
microtubule-actin cross-linking factor 1-like isoform X7
microtubule-actin cross-linking factor 1-like isoform X46
microtubule-actin cross-linking factor 1-like isoform X38
microtubule-actin cross-linking factor 1-like isoform X20
microtubule-actin cross-linking factor 1-like isoform X17
microtubule-actin cross-linking factor 1-like isoform X41
microtubule-actin cross-linking factor 1-like isoform X25
microtubule-actin cross-linking factor 1-like isoform X2
microtubule-actin cross-linking factor 1-like isoform X40
microtubule-actin cross-linking factor 1-like isoform X36
microtubule-actin cross-linking factor 1-like isoform X27
microtubule-actin cross-linking factor 1-like isoform X8
microtubule-actin cross-linking factor 1-like isoform X34
microtubule-actin cross-linking factor 1-like isoform X42
microtubule-actin cross-linking factor 1-like isoform X28
microtubule-actin cross-linking factor 1-like isoform X16
microtubule-actin cross-linking factor 1-like isoform X32
microtubule-actin cross-linking factor 1-like isoform X15
microtubule-actin cross-linking factor 1-like isoform X14
microtubule-actin cross-linking factor 1-like isoform X3
microtubule-actin cross-linking factor 1-like isoform X39
microtubule-actin cross-linking factor 1-like isoform X37
microtubule-actin cross-linking factor 1-like isoform X35
microtubule-actin cross-linking factor 1-like isoform X30
microtubule-actin cross-linking factor 1-like isoform X29
microtubule-actin cross-linking factor 1-like isoform X21
microtubule-actin cross-linking factor 1-like isoform X33
microtubule-actin cross-linking factor 1-like isoform X31
microtubule-actin cross-linking factor 1-like isoform X22
microtubule-actin cross-linking factor 1-like isoform X13
microtubule-actin cross-linking factor 1-like isoform X6
microtubule-actin cross-linking factor 1-like isoform X18
microtubule-actin cross-linking factor 1-like isoform X9
microtubule-actin cross-linking factor 1-like isoform X23
microtubule-actin cross-linking factor 1-like isoform X19
microtubule-actin cross-linking factor 1-like isoform X12
microtubule-actin cross-linking factor 1-like isoform X10
microtubule-actin cross-linking factor 1-like isoform X4
microtubule-actin cross-linking factor 1-like isoform X5
microtubule-actin cross-linking factor 1-like isoform X1
microtubule-actin cross-linking factor 1-like isoform X26
microtubule-actin cross-linking factor 1-like isoform X24
microtubule-actin cross-linking factor 1-like isoform X43
uncharacterized protein LOC123504409 isoform X47
microtubule-actin cross-linking factor 1-like isoform X45
microtubule-actin cross-linking factor 1-like isoform X44
uncharacterized LOC123504415, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123504415, transcript variant X3
uncharacterized LOC123504415, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123504415, transcript variant X4
nucleolar pre-ribosomal-associated protein 1-like
sodium-dependent phosphate transport protein 1, chloroplastic-like, transcript variant X2
sodium-dependent phosphate transport protein 1, chloroplastic-like, transcript variant X1
sodium-dependent phosphate transport protein 1, chloroplastic-like isoform X1
sodium-dependent phosphate transport protein 1, chloroplastic-like isoform X2
glutamate receptor ionotropic, delta-2-like
LOW QUALITY PROTEIN: solute carrier family 15 member 4-like
tip elongation aberrant protein 1-like, transcript variant X2
tip elongation aberrant protein 1-like, transcript variant X1
tip elongation aberrant protein 1-like isoform X1
uncharacterized protein LOC123504579 isoform X2
protein MCM10 homolog, transcript variant X12
protein MCM10 homolog, transcript variant X9
protein MCM10 homolog, transcript variant X17
protein MCM10 homolog, transcript variant X18
protein MCM10 homolog, transcript variant X13
protein MCM10 homolog, transcript variant X19
protein MCM10 homolog, transcript variant X10
protein MCM10 homolog, transcript variant X6
protein MCM10 homolog, transcript variant X7
protein MCM10 homolog, transcript variant X4
protein MCM10 homolog, transcript variant X5
protein MCM10 homolog, transcript variant X8
protein MCM10 homolog, transcript variant X15
protein MCM10 homolog, transcript variant X16
protein MCM10 homolog, transcript variant X3
protein MCM10 homolog, transcript variant X2
protein MCM10 homolog, transcript variant X1
protein MCM10 homolog, transcript variant X11
protein MCM10 homolog, transcript variant X14
gamma-2-syntrophin-like, transcript variant X1
gamma-2-syntrophin-like, transcript variant X3
gamma-2-syntrophin-like, transcript variant X2
uncharacterized LOC123504541, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC123504541 isoform X3
uncharacterized LOC123504541, transcript variant X2
uncharacterized LOC123504541, transcript variant X1
uncharacterized protein LOC123504541 isoform X1
uncharacterized LOC123504541, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC123504541 isoform X2
isoleucine--tRNA ligase, mitochondrial-like, transcript variant X1
isoleucine--tRNA ligase, mitochondrial-like isoform X1
isoleucine--tRNA ligase, mitochondrial-like, transcript variant X4
isoleucine--tRNA ligase, mitochondrial-like isoform X4
isoleucine--tRNA ligase, mitochondrial-like, transcript variant X2
isoleucine--tRNA ligase, mitochondrial-like, transcript variant X3
isoleucine--tRNA ligase, mitochondrial-like isoform X3
isoleucine--tRNA ligase, mitochondrial-like isoform X2
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X2
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X11
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X12
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X3
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X4
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X5
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X6
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X8
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X1
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X10
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X7
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X9
inositol 1,4,5-trisphosphate receptor type 1-like, transcript variant X13
inositol 1,4,5-trisphosphate receptor type 1-like isoform X2
inositol 1,4,5-trisphosphate receptor type 1-like isoform X3
inositol 1,4,5-trisphosphate receptor type 1-like isoform X4
inositol 1,4,5-trisphosphate receptor type 1-like isoform X6
inositol 1,4,5-trisphosphate receptor type 1-like isoform X1
inositol 1,4,5-trisphosphate receptor type 1-like isoform X7
inositol 1,4,5-trisphosphate receptor type 1-like isoform X8
inositol 1,4,5-trisphosphate receptor type 1-like isoform X5
inositol 1,4,5-trisphosphate receptor type 1-like isoform X9
inositol 1,4,5-trisphosphate receptor-like isoform X11
inositol 1,4,5-trisphosphate receptor type 1-like isoform X10
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
probable protein phosphatase 2C 56, transcript variant X1
protein kinase and PP2C-like domain-containing protein isoform X1
probable protein phosphatase 2C 56, transcript variant X2
probable protein phosphatase 2C 56 isoform X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like isoform X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like, transcript variant X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like isoform X2
tubulin beta chain-like, transcript variant X2
tubulin beta chain-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X8
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X10
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X9
ubiquitin carboxyl-terminal hydrolase 47-like isoform X7
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X7
ubiquitin carboxyl-terminal hydrolase 47-like isoform X6
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X11
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X12
ubiquitin carboxyl-terminal hydrolase 47-like isoform X4
ubiquitin carboxyl-terminal hydrolase 47-like isoform X1
ubiquitin carboxyl-terminal hydrolase 47-like isoform X3
ubiquitin carboxyl-terminal hydrolase 47-like isoform X2
ubiquitin carboxyl-terminal hydrolase 47-like, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 47-like isoform X5
ubiquitin carboxyl-terminal hydrolase 47-like isoform X8
ubiquitin carboxyl-terminal hydrolase 47-like isoform X9
uncharacterized LOC123504495, transcript variant X1
uncharacterized LOC123504495, transcript variant X2
uncharacterized LOC123504495, transcript variant X3
uncharacterized protein LOC123504495 isoform X2
uncharacterized protein LOC123504495 isoform X3
uncharacterized protein LOC123504495 isoform X1
uncharacterized LOC123504501, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123504501, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123504565, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123504565, transcript variant X1
galactose-1-phosphate uridylyltransferase-like
beta-1,4-galactosyltransferase galt-1-like, transcript variant X1
beta-1,4-galactosyltransferase galt-1-like, transcript variant X2
beta-1,4-galactosyltransferase galt-1-like isoform X1
uncharacterized protein LOC123504586 isoform X2
beta,beta-carotene 15,15'-dioxygenase-like
uncharacterized LOC123504604, transcript variant X1
uncharacterized LOC123504604, transcript variant X2
uncharacterized protein LOC123504604 isoform X1
uncharacterized protein LOC123504604 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cardioacceleratory peptide receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X1
cardioacceleratory peptide receptor-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X6
cardioacceleratory peptide receptor-like, transcript variant X8
cardioacceleratory peptide receptor-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cardioacceleratory peptide receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cardioacceleratory peptide receptor-like isoform X1
cardioacceleratory peptide receptor-like isoform X2
cardioacceleratory peptide receptor-like isoform X3
cardioacceleratory peptide receptor-like isoform X4
cardioacceleratory peptide receptor-like isoform X5
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like, transcript variant X1
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like, transcript variant X2
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like
serine/threonine-protein kinase pakA-like
uncharacterized LOC123504670, transcript variant X1
uncharacterized protein LOC123504670 isoform X1
uncharacterized LOC123504670, transcript variant X2
uncharacterized protein LOC123504670 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123504635
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC123504644 isoform X3
uncharacterized protein LOC123504644 isoform X2
uncharacterized protein LOC123504644 isoform X4
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like, transcript variant X1
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X1
malonate--CoA ligase ACSF3, mitochondrial-like, transcript variant X4
malonate--CoA ligase ACSF3, mitochondrial-like, transcript variant X1
malonate--CoA ligase ACSF3, mitochondrial-like, transcript variant X2
malonate--CoA ligase ACSF3, mitochondrial-like, transcript variant X5
malonate--CoA ligase ACSF3, mitochondrial-like isoform X1
malonate--CoA ligase ACSF3, mitochondrial-like isoform X4
malonate--CoA ligase ACSF3, mitochondrial-like isoform X3
malonate--CoA ligase ACSF3, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
malonate--CoA ligase ACSF3, mitochondrial-like isoform X2
zinc finger protein 431-like, transcript variant X1
zinc finger protein 431-like, transcript variant X3
zinc finger protein 431-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
angio-associated migratory cell protein-like, transcript variant X1
angio-associated migratory cell protein-like, transcript variant X2
angio-associated migratory cell protein-like, transcript variant X3
angio-associated migratory cell protein-like
putative uncharacterized protein DDB_G0291608
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments
polyadenylate-binding protein 2-like, transcript variant X3
polyadenylate-binding protein 2-like isoform X2
polyadenylate-binding protein 2-like, transcript variant X5
polyadenylate-binding protein 2-like isoform X4
polyadenylate-binding protein 2-like, transcript variant X1
polyadenylate-binding protein 2-like, transcript variant X2
polyadenylate-binding protein 2-like isoform X1
polyadenylate-binding protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
polyadenylate-binding protein 2-like isoform X3
sphingosine-1-phosphate lyase-like, transcript variant X1
sphingosine-1-phosphate lyase-like isoform X1
sphingosine-1-phosphate lyase-like, transcript variant X2
sphingosine-1-phosphate lyase-like isoform X2
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase-like, transcript variant X3
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase-like, transcript variant X2
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase-like, transcript variant X1
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase-like isoform X2
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase-like isoform X1
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4-like isoform X3
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X3
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, transcript variant X4
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X2
putative uncharacterized protein DDB_G0291608, transcript variant X1
putative uncharacterized protein DDB_G0291608, transcript variant X5
putative uncharacterized protein DDB_G0291608, transcript variant X3
putative uncharacterized protein DDB_G0291608, transcript variant X4
putative uncharacterized protein DDB_G0291608, transcript variant X8
putative uncharacterized protein DDB_G0291608, transcript variant X2
putative uncharacterized protein DDB_G0291608, transcript variant X6
putative uncharacterized protein DDB_G0291608, transcript variant X7
putative uncharacterized protein DDB_G0291608, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative uncharacterized protein DDB_G0291608, transcript variant X13
putative uncharacterized protein DDB_G0291608, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative uncharacterized protein DDB_G0291608, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC123504660 isoform X1
uncharacterized protein LOC123504660 isoform X2
uncharacterized protein LOC123504660 isoform X3
uncharacterized protein LOC123504660 isoform X4
putative uncharacterized protein DDB_G0291608 isoform X5
putative uncharacterized protein DDB_G0291608, transcript variant X10
putative uncharacterized protein DDB_G0291608, transcript variant X12
putative uncharacterized protein DDB_G0291608, transcript variant X11
leucine-rich repeat extensin-like protein 5
LOW QUALITY PROTEIN: leucine-rich repeat extensin-like protein 5
rab GTPase-activating protein 1-like, transcript variant X5
rab GTPase-activating protein 1-like, transcript variant X8
rab GTPase-activating protein 1-like, transcript variant X4
rab GTPase-activating protein 1-like, transcript variant X2
rab GTPase-activating protein 1-like, transcript variant X1
rab GTPase-activating protein 1-like, transcript variant X7
rab GTPase-activating protein 1-like, transcript variant X6
rab GTPase-activating protein 1-like, transcript variant X9
rab GTPase-activating protein 1-like, transcript variant X3
rab GTPase-activating protein 1-like, transcript variant X10
rab GTPase-activating protein 1-like isoform X5
rab GTPase-activating protein 1-like isoform X4
rab GTPase-activating protein 1-like isoform X2
rab GTPase-activating protein 1-like isoform X1
rab GTPase-activating protein 1-like isoform X3
uncharacterized LOC123504665, transcript variant X2
uncharacterized LOC123504665, transcript variant X1
uncharacterized protein LOC123504665 isoform X2
uncharacterized protein LOC123504665 isoform X1
jerky protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
jerky protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like
uncharacterized LOC123504617, transcript variant X1
uncharacterized LOC123504617, transcript variant X3
uncharacterized LOC123504617, transcript variant X2
uncharacterized LOC123504617, transcript variant X5
uncharacterized LOC123504617, transcript variant X6
uncharacterized LOC123504617, transcript variant X4
uncharacterized protein LOC123504617 isoform X1
uncharacterized protein LOC123504617 isoform X3
uncharacterized protein LOC123504617 isoform X2
uncharacterized protein LOC123504617 isoform X5
uncharacterized protein LOC123504617 isoform X6
uncharacterized protein LOC123504617 isoform X4
phosphotriesterase-related protein-like, transcript variant X2
phosphotriesterase-related protein-like, transcript variant X3
phosphotriesterase-related protein-like, transcript variant X1
phosphotriesterase-related protein-like, transcript variant X4
phosphotriesterase-related protein-like isoform X2
phosphotriesterase-related protein-like isoform X3
phosphotriesterase-related protein-like isoform X1
phosphotriesterase-related protein-like isoform X4
extracellular serine/threonine protein CG31145-like
LOW QUALITY PROTEIN: extracellular serine/threonine protein CG31145-like
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized PE-PGRS family protein PE_PGRS54-like
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123504596, transcript variant X3
uncharacterized LOC123504596, transcript variant X4
uncharacterized protein LOC123504596 isoform X3
uncharacterized LOC123504596, transcript variant X2
uncharacterized LOC123504596, transcript variant X5
uncharacterized protein LOC123504596 isoform X2
uncharacterized LOC123504596, transcript variant X1
uncharacterized protein LOC123504596 isoform X1
uncharacterized LOC123504598, transcript variant X1
uncharacterized LOC123504598, transcript variant X2
probable cytochrome P450 49a1, transcript variant X2
probable cytochrome P450 49a1, transcript variant X1
probable cytochrome P450 49a1, transcript variant X3
probable cytochrome P450 49a1 isoform X1
probable cytochrome P450 49a1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
GTP-binding protein 1-like, transcript variant X2
GTP-binding protein 1-like, transcript variant X1
GTP-binding protein 1-like, transcript variant X3
GTP-binding protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC2-like, transcript variant X3
protein O-mannosyl-transferase TMTC2-like isoform X3
protein O-mannosyl-transferase TMTC2-like, transcript variant X2
protein O-mannosyl-transferase TMTC2-like, transcript variant X1
protein O-mannosyl-transferase TMTC2-like isoform X1
protein O-mannosyl-transferase TMTC2-like isoform X2
LOW QUALITY PROTEIN: uncharacterized protein LOC123504568
uncharacterized LOC123504569, transcript variant X1
uncharacterized LOC123504569, transcript variant X2
uncharacterized LOC123504570, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123504570, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123504570, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: flocculation protein FLO11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dnaJ homolog subfamily A member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 long SRA reads, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
blastula protease 10-like, transcript variant X4
blastula protease 10-like, transcript variant X3
blastula protease 10-like, transcript variant X2
blastula protease 10-like, transcript variant X1
betaine--homocysteine S-methyltransferase 1-like, transcript variant X3
betaine--homocysteine S-methyltransferase 1-like, transcript variant X2
betaine--homocysteine S-methyltransferase 1-like, transcript variant X1
betaine--homocysteine S-methyltransferase 1-like, transcript variant X4
betaine--homocysteine S-methyltransferase 1-like isoform X2
S-methylmethionine--homocysteine S-methyltransferase BHMT2-like isoform X1
betaine--homocysteine S-methyltransferase 1-like isoform X3
betaine--homocysteine S-methyltransferase 1-like isoform X4
betaine--homocysteine S-methyltransferase 1-like
S-methylmethionine--homocysteine S-methyltransferase BHMT2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
chymotrypsin-like protease CTRL-1, transcript variant X1
chymotrypsin-like protease CTRL-1, transcript variant X2
venom serine protease 34-like isoform X2
chymotrypsin-like protease CTRL-1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123504543, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC123504543 isoform X4
uncharacterized LOC123504543, transcript variant X5
uncharacterized protein LOC123504543 isoform X5
uncharacterized LOC123504543, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123504543, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC123504543 isoform X1
uncharacterized protein LOC123504543 isoform X2
uncharacterized LOC123504543, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC123504543 isoform X3
transforming growth factor beta-1-induced transcript 1 protein-like isoform X10
transforming growth factor beta-1-induced transcript 1 protein-like isoform X9
uncharacterized LOC123504634, transcript variant X2
uncharacterized LOC123504634, transcript variant X3
uncharacterized LOC123504634, transcript variant X4
uncharacterized LOC123504634, transcript variant X1
actin-related protein 5-like, transcript variant X2
actin-related protein 5-like, transcript variant X1
uncharacterized LOC123504622, transcript variant X2
uncharacterized LOC123504622, transcript variant X8
uncharacterized LOC123504622, transcript variant X7
uncharacterized LOC123504622, transcript variant X5
uncharacterized LOC123504622, transcript variant X1
uncharacterized LOC123504622, transcript variant X6
uncharacterized LOC123504622, transcript variant X9
uncharacterized LOC123504622, transcript variant X4
uncharacterized LOC123504622, transcript variant X3
uncharacterized protein LOC123504622 isoform X2
uncharacterized protein LOC123504622 isoform X1
uncharacterized protein LOC123504622 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
sulfotransferase 1A1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sulfotransferase 1A1-like, transcript variant X2
sulfotransferase 1A1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sulfotransferase 1A1-like, transcript variant X5
sulfotransferase 1A1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
sulfotransferase 1A1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sulfotransferase 1A1-like, transcript variant X7
uncharacterized LOC123504575, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123504575, transcript variant X2
uncharacterized LOC123504520, transcript variant X1
uncharacterized LOC123504520, transcript variant X2
uncharacterized LOC123504614, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123504614, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123504614, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123504629, transcript variant X1
uncharacterized LOC123504629, transcript variant X2
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123504606, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123504606, transcript variant X1
uncharacterized protein LOC123504606 isoform X2
uncharacterized protein LOC123504606 isoform X1
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123504666, transcript variant X6
uncharacterized LOC123504666, transcript variant X1
uncharacterized LOC123504666, transcript variant X3
uncharacterized LOC123504666, transcript variant X5
uncharacterized LOC123504666, transcript variant X4
uncharacterized LOC123504666, transcript variant X7
uncharacterized LOC123504666, transcript variant X2
uncharacterized protein LOC123504666 isoform X2
uncharacterized protein LOC123504666 isoform X1
ras GTPase-activating protein 3-like, transcript variant X2
ras GTPase-activating protein 3-like, transcript variant X1
ras GTPase-activating protein 3-like isoform X2
ras GTPase-activating protein 3-like isoform X1
putative uncharacterized protein DDB_G0292292, transcript variant X3
putative uncharacterized protein DDB_G0292292, transcript variant X2
putative uncharacterized protein DDB_G0292292, transcript variant X1
putative uncharacterized protein DDB_G0292292, transcript variant X4
putative uncharacterized protein DDB_G0292292 isoform X2
putative uncharacterized protein DDB_G0292292 isoform X1
putative uncharacterized protein DDB_G0292292 isoform X3
next to BRCA1 gene 1 protein-like, transcript variant X2
next to BRCA1 gene 1 protein-like, transcript variant X1
next to BRCA1 gene 1 protein-like isoform X1
next to BRCA1 gene 1 protein-like isoform X2
translin-associated factor X-interacting protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123504488, transcript variant X1
uncharacterized protein LOC123504488 isoform X1
uncharacterized LOC123504488, transcript variant X2
uncharacterized protein LOC123504488 isoform X2
uncharacterized LOC123504488, transcript variant X3
uncharacterized protein LOC123504488 isoform X3
ATP-binding cassette sub-family C member 9-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ATP-binding cassette sub-family C member 9-like
ATP-dependent DNA/RNA helicase DHX36-like
LOW QUALITY PROTEIN: ATP-dependent DNA/RNA helicase DHX36-like
transmembrane protein 129-like, transcript variant X3
transmembrane protein 129-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transmembrane protein 129-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane protein 129-like isoform X3
transmembrane protein 129-like isoform X1
transmembrane protein 129-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
probable ribosome biogenesis protein RLP24
uncharacterized LOC123504395, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized protein LOC123504395 isoform X2
uncharacterized LOC123504395, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123504395, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC123504395 isoform X1
uncharacterized protein LOC123504395 isoform X3
dihydrolipoyl dehydrogenase, mitochondrial-like
zinc finger HIT domain-containing protein 2-like
uncharacterized LOC123504590, transcript variant X3
uncharacterized LOC123504590, transcript variant X2
uncharacterized LOC123504590, transcript variant X1
uncharacterized LOC123504590, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
probable 3',5'-cyclic phosphodiesterase pde-5
LOW QUALITY PROTEIN: probable 3',5'-cyclic phosphodiesterase pde-5
beta-1,4-glucuronyltransferase 1-like, transcript variant X1
beta-1,4-glucuronyltransferase 1-like, transcript variant X4
beta-1,4-glucuronyltransferase 1-like, transcript variant X2
beta-1,4-glucuronyltransferase 1-like, transcript variant X3
beta-1,4-glucuronyltransferase 1-like isoform X2
beta-1,4-glucuronyltransferase 1-like isoform X1
beta-1,4-glucuronyltransferase 1-like isoform X3
beta-1,4-glucuronyltransferase 1-like, transcript variant X5
beta-1,4-glucuronyltransferase 1-like, transcript variant X7
beta-1,4-glucuronyltransferase 1-like, transcript variant X6
uncharacterized protein LOC123504487 isoform X2
uncharacterized protein LOC123504487 isoform X1
beta-1,4-glucuronyltransferase 1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized LOC123504405, transcript variant X1
uncharacterized LOC123504405, transcript variant X2
class A basic helix-loop-helix protein 15-like
receptor-type tyrosine-protein phosphatase kappa-like, transcript variant X1
receptor-type tyrosine-protein phosphatase kappa-like, transcript variant X2
receptor-type tyrosine-protein phosphatase kappa-like, transcript variant X3
receptor-type tyrosine-protein phosphatase kappa-like, transcript variant X4
receptor-type tyrosine-protein phosphatase kappa-like isoform X1
receptor-type tyrosine-protein phosphatase kappa-like isoform X2
receptor-type tyrosine-protein phosphatase kappa-like isoform X4
receptor-type tyrosine-protein phosphatase kappa-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
apolipoprotein D-like, transcript variant X1
apolipoprotein D-like, transcript variant X2
uncharacterized LOC123504600, transcript variant X2
uncharacterized LOC123504600, transcript variant X1
uncharacterized protein LOC123504600 isoform X2
uncharacterized protein LOC123504600 isoform X1
uncharacterized LOC123504601, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123504601, transcript variant X1
kinetochore protein NDC80 homolog, transcript variant X2
kinetochore protein NDC80 homolog, transcript variant X1
formylglycine-generating enzyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
formylglycine-generating enzyme-like, transcript variant X1
vacuolar protein sorting-associated protein 37A-like, transcript variant X7
vacuolar protein sorting-associated protein 37A-like, transcript variant X6
vacuolar protein sorting-associated protein 37A-like, transcript variant X2
vacuolar protein sorting-associated protein 37A-like, transcript variant X1
vacuolar protein sorting-associated protein 37A-like, transcript variant X4
vacuolar protein sorting-associated protein 37A-like, transcript variant X3
vacuolar protein sorting-associated protein 37A-like, transcript variant X8
vacuolar protein sorting-associated protein 37A-like, transcript variant X9
vacuolar protein sorting-associated protein 37A-like, transcript variant X5
vacuolar protein sorting-associated protein 37A-like isoform X1
vacuolar protein sorting-associated protein 37A-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: protein vestigial-like
transcription cofactor vestigial-like protein 2, transcript variant X4
transcription cofactor vestigial-like protein 2, transcript variant X1
transcription cofactor vestigial-like protein 2, transcript variant X2
transcription cofactor vestigial-like protein 2, transcript variant X3
transcription cofactor vestigial-like protein 2 isoform X2
transcription cofactor vestigial-like protein 2 isoform X1
helicase POLQ-like, transcript variant X1
helicase POLQ-like, transcript variant X2
uncharacterized LOC123504558, transcript variant X2
uncharacterized LOC123504558, transcript variant X1
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
delta-sarcoglycan-like, transcript variant X4
delta-sarcoglycan-like, transcript variant X2
delta-sarcoglycan-like, transcript variant X3
delta-sarcoglycan-like, transcript variant X5
delta-sarcoglycan-like, transcript variant X1
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uridine diphosphate glucose pyrophosphatase NUDT22-like
eukaryotic elongation factor 2 kinase-like, transcript variant X4
eukaryotic elongation factor 2 kinase-like, transcript variant X3
eukaryotic elongation factor 2 kinase-like, transcript variant X1
eukaryotic elongation factor 2 kinase-like, transcript variant X2
eukaryotic elongation factor 2 kinase-like, transcript variant X5
eukaryotic elongation factor 2 kinase-like, transcript variant X6
eukaryotic elongation factor 2 kinase-like isoform X1
eukaryotic elongation factor 2 kinase-like isoform X2
actin-interacting protein 1-like, transcript variant X3
actin-interacting protein 1-like, transcript variant X4
actin-interacting protein 1-like isoform X4
actin-interacting protein 1-like isoform X3
actin-interacting protein 1-like, transcript variant X2
actin-interacting protein 1-like, transcript variant X1
actin-interacting protein 1-like isoform X1
actin-interacting protein 1-like isoform X2
uncharacterized LOC123504453, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123504453, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123504453, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized protein LOC123504453 isoform X1
uncharacterized protein LOC123504453 isoform X2
uncharacterized protein LOC123504453 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
CUGBP Elav-like family member 2, transcript variant X17
CUGBP Elav-like family member 2, transcript variant X6
CUGBP Elav-like family member 2, transcript variant X8
CUGBP Elav-like family member 2, transcript variant X20
CUGBP Elav-like family member 2, transcript variant X4
CUGBP Elav-like family member 2, transcript variant X2
CUGBP Elav-like family member 2, transcript variant X1
CUGBP Elav-like family member 2, transcript variant X5
CUGBP Elav-like family member 2, transcript variant X3
CUGBP Elav-like family member 2, transcript variant X9
CUGBP Elav-like family member 2, transcript variant X14
CUGBP Elav-like family member 2, transcript variant X12
CUGBP Elav-like family member 2, transcript variant X7
CUGBP Elav-like family member 2, transcript variant X16
CUGBP Elav-like family member 2, transcript variant X11
CUGBP Elav-like family member 2, transcript variant X10
CUGBP Elav-like family member 2, transcript variant X19
CUGBP Elav-like family member 2, transcript variant X18
CUGBP Elav-like family member 2, transcript variant X15
CUGBP Elav-like family member 2, transcript variant X13
CUGBP Elav-like family member 2 isoform X5
CUGBP Elav-like family member 2 isoform X14
CUGBP Elav-like family member 2 isoform X9
CUGBP Elav-like family member 2 isoform X4
CUGBP Elav-like family member 2 isoform X2
CUGBP Elav-like family member 2 isoform X12
CUGBP Elav-like family member 2 isoform X7
CUGBP Elav-like family member 2 isoform X20
CUGBP Elav-like family member 2 isoform X17
CUGBP Elav-like family member 2 isoform X8
CUGBP Elav-like family member 2 isoform X6
CUGBP Elav-like family member 2 isoform X3
CUGBP Elav-like family member 2 isoform X1
CUGBP Elav-like family member 2 isoform X16
CUGBP Elav-like family member 2 isoform X11
CUGBP Elav-like family member 2 isoform X10
CUGBP Elav-like family member 2 isoform X19
CUGBP Elav-like family member 2 isoform X18
CUGBP Elav-like family member 2 isoform X15
CUGBP Elav-like family member 2 isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
golgin subfamily A member 5-like, transcript variant X2
golgin subfamily A member 5-like, transcript variant X1
golgin subfamily A member 5-like, transcript variant X3
golgin subfamily A member 5-like isoform X2
golgin subfamily A member 5-like isoform X1
golgin subfamily A member 5-like isoform X3
protein asteroid-like, transcript variant X2
protein asteroid-like, transcript variant X1
protein asteroid-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein K02A2.6-like
Na(+)/H(+) exchange regulatory cofactor NHE-RF1-like
LOW QUALITY PROTEIN: Na(+)/H(+) exchange regulatory cofactor NHE-RF1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123504510, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123504510, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC123504511, transcript variant X1
uncharacterized protein LOC123504511 isoform X1
uncharacterized LOC123504511, transcript variant X2
uncharacterized protein LOC123504511 isoform X2
cytosolic carboxypeptidase Nna1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytosolic carboxypeptidase Nna1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
piggyBac transposable element-derived protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
cytosolic carboxypeptidase Nna1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytosolic carboxypeptidase Nna1-like isoform X3
cytosolic carboxypeptidase Nna1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytosolic carboxypeptidase Nna1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cytosolic carboxypeptidase Nna1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytosolic carboxypeptidase Nna1-like isoform X1
cytosolic carboxypeptidase Nna1-like isoform X2
cytosolic carboxypeptidase Nna1-like isoform X5
cytosolic carboxypeptidase Nna1-like isoform X4
cytosolic carboxypeptidase Nna1-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123504522, transcript variant X3
uncharacterized LOC123504522, transcript variant X2
uncharacterized LOC123504522, transcript variant X1
uncharacterized LOC123504522, transcript variant X4
uncharacterized LOC123504522, transcript variant X8
uncharacterized LOC123504522, transcript variant X5
uncharacterized LOC123504522, transcript variant X6
uncharacterized LOC123504522, transcript variant X7
uncharacterized protein LOC123504522 isoform X1
uncharacterized protein LOC123504522 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
myb-like protein I, transcript variant X2
myb-like protein I, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
POU domain, class 3, transcription factor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized LOC123504534, transcript variant X2
uncharacterized LOC123504534, transcript variant X1
uncharacterized LOC123504534, transcript variant X3
uncharacterized protein LOC123504534 isoform X1
uncharacterized protein LOC123504534 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
LOW QUALITY PROTEIN: uncharacterized protein LOC123504535
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
AF4/FMR2 family member lilli-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
AF4/FMR2 family member lilli-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns